Insider Selling: Uniphar (LON:UPR) Insider Sells £156,945.10 in Stock

Uniphar plc (LON:UPR) insider Gerard Rabbette sold 43,355 shares of the business’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of GBX 362, for a total value of £156,945.10.

Uniphar Price Performance

UPR stock opened at GBX 310 on Monday. Uniphar plc has a one year low of GBX 163 and a one year high of GBX 368. The firm has a market capitalization of £804.68 million, a PE ratio of 12.65 and a beta of 0.75. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48. The firm has a 50-day moving average of GBX 330.76 and a two-hundred day moving average of GBX 331.02.

Analyst Ratings Changes

Separately, Royal Bank Of Canada boosted their price objective on Uniphar from GBX 470 to GBX 480 and gave the company an “outperform” rating in a report on Tuesday, September 9th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of GBX 427.50.

About Uniphar

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.